NCT05740215 2023-02-22Efficacy and Safety Study of F520 Combined With Lenvatinib in the Treatment of Patients With Advanced Solid TumorsShandong New Time Pharmaceutical Co., LTDPhase 1/2 Unknown158 enrolled